Maintenance fees coming due
6 maintenance fees come due in the 12 months from Nov 18, 2026, the next on Dec 20, 2026. Unpaid by Jun 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,679,117 | Ganaxolone for Use in Treatment of Status Epilepticus In force Fee due Dec 20, 2026 Lapses if unpaid Jun 21, 2027 · Medium confidence | Immedica Pharma US Inc. | In force | Dec 20, 2026 | Jun 21, 2027 | Medium confidence | |
| US 11,701,367 | Ganaxolone for Use in Treating Tuberous Sclerosis Complex In force Fee due Jan 18, 2027 Lapses if unpaid Jul 19, 2027 · Medium confidence | Immedica Pharma US Inc. | In force | Jan 18, 2027 | Jul 19, 2027 | Medium confidence | |
| US 11,717,562 | Method and Composition for Treating Arginase 1 Deficiency In force Fee due Feb 8, 2027 Lapses if unpaid Aug 9, 2027 · High confidence | Immedica Pharma AB | In force | Feb 8, 2027 | Aug 9, 2027 | High confidence | |
| US 10,391,105 | Methods of Treating Certain Depressive Disorders and Delirium Tremens In force Fee due Feb 27, 2027 Lapses if unpaid Aug 27, 2027 · High confidence | Immedica Pharma US Inc. | In force | Feb 27, 2027 | Aug 27, 2027 | High confidence | |
| US 10,639,317 | Methods of Treating Certain Depressive Disorders and Delirium Tremens In force Fee due Nov 5, 2027 Lapses if unpaid May 5, 2028 · High confidence | Immedica Pharma US Inc. | In force | Nov 5, 2027 | May 5, 2028 | High confidence | |
| US 11,980,625 | Ganaxolone for Use in Treating Tuberous Sclerosis Complex In force Fee due Nov 14, 2027 Lapses if unpaid May 15, 2028 · Medium confidence | Immedica Pharma US Inc. | In force | Nov 14, 2027 | May 15, 2028 | Medium confidence |
6 of 6 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.